TP53 and lung carcinoma: These nanoparticles were designed to co-encapsulate near-infrared fluorescent dyes, specifically methylene blue (MB), along with p53 plasmids, leading to the development of MB-NSi-p53-CS ternary complexes aimed at the targeted imaging of tumors and the application of p53 gene therapy in the treatment of lung cancer.